The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(4-((6-Methoxypyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea ID: ALA4876578
PubChem CID: 164625745
Max Phase: Preclinical
Molecular Formula: C19H15F3N4O3
Molecular Weight: 404.35
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ncn1
Standard InChI: InChI=1S/C19H15F3N4O3/c1-28-16-10-17(24-11-23-16)29-15-7-5-13(6-8-15)25-18(27)26-14-4-2-3-12(9-14)19(20,21)22/h2-11H,1H3,(H2,25,26,27)
Standard InChI Key: LIKUFHJAWCSTNE-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
24.5900 -28.5398 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
24.1856 -29.2497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0026 -29.2450 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.9887 -28.0651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9875 -28.8847 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.4024 -28.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6938 -27.6563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1086 -27.6503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.8178 -28.0562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8176 -28.8710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5260 -29.2769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2331 -28.8656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2274 -28.0442 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5184 -27.6420 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9429 -29.2706 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6485 -28.8584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3583 -29.2633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.6443 -28.0412 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0639 -28.8511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7718 -29.2579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4769 -28.8464 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4732 -28.0284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7585 -27.6236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0562 -28.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.1903 -30.0689 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.4098 -28.8839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6948 -29.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6932 -30.1086 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.9846 -30.5158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 5 2 0
5 27 1 0
26 6 1 0
6 7 2 0
7 4 1 0
6 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
12 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
21 2 1 0
2 25 1 0
26 27 2 0
27 28 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 404.35Molecular Weight (Monoisotopic): 404.1096AlogP: 4.94#Rotatable Bonds: 5Polar Surface Area: 85.37Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 11.53CX Basic pKa: 2.83CX LogP: 4.60CX LogD: 4.60Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.63Np Likeness Score: -1.66
References 1. Patterson JR, Graves AP, Stoy P, Cheung M, Desai TA, Fries H, Gatto GJ, Holt DA, Shewchuk L, Totoritis R, Wang L, Kallander LS.. (2021) Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf., 64 (21.0): [PMID:34699203 ] [10.1021/acs.jmedchem.1c00700 ]